Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: Lee Fredrickson who wrote (589)	11/10/1998 10:42:00 AM
From: Marty	Read Replies (1) \| Respond to of 705

Thanks for the link to the article. This is the results on just one of the phase 1 tests. Too bad they just wrote about how safe it is and how well it was tolerated and didn't include any of the episodes about just how well it worked to restore memory. That was a bonus. I think they have established the optimum dosage already as well by now. The big thing when they did this test whether or not the drug got through the brain blood barrier for effective delivery mechanism.